Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Convulsions after treatment with pyrazinamide.

P Herlevsen1, C Nielsen, J T Pedersen

  • 1Department of Respiratory Medicine, Aalborg Hospital, Denmark.

Tubercle
|June 1, 1987
PubMed
Summary

Pyrazinamide, a tuberculosis drug, may cause convulsions in children. This case highlights a potential adverse effect in pediatric pulmonary tuberculosis treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Search for Light Pseudoscalar Bosons, Pair-Produced in Higgs Boson Decays in the Four-Electron Final State in Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2026
Same author

First Evidence for Mixing-Induced CP Violation in B_{s}^{0}→J/ψϕ(1020) Decays in pp Collisions at sqrt[s]=13  TeV.

Physical review letters·2026
Same author

Observation of Suppressed Charged-Particle Production in Ultrarelativistic Oxygen-Oxygen Collisions.

Physical review letters·2026
Same author

Measurement of D^{0} Meson Photoproduction in Ultraperipheral Heavy Ion Collisions.

Physical review letters·2026
Same author

Observation of tWZ Production at the CMS Experiment.

Physical review letters·2026
Same author

First Exclusive Reconstruction of the B^{*+}, B^{*0}, and B_{s}^{*0} Mesons and Precise Measurement of Their Masses.

Physical review letters·2026

Area of Science:

  • Pediatric Pulmonology
  • Clinical Pharmacology
  • Infectious Diseases

Background:

  • Tuberculosis remains a significant global health challenge, particularly in pediatric populations.
  • Effective treatment regimens are crucial for managing pediatric pulmonary tuberculosis.
  • Understanding drug-induced adverse events is vital for patient safety.

Observation:

  • A 2-year-old boy diagnosed with pulmonary tuberculosis presented with new-onset convulsions.
  • The convulsions emerged during the course of anti-tuberculosis treatment.
  • The clinical presentation suggested a potential link between pyrazinamide and the observed seizures.

Findings:

  • Pyrazinamide, a first-line anti-tuberculosis medication, was administered as part of the treatment regimen.
  • The temporal association between pyrazinamide initiation and the onset of convulsions was noted.
  • This case suggests pyrazinamide as a potential causative agent for seizures in this pediatric patient.

Implications:

  • Clinicians should be vigilant for neurological adverse effects, such as convulsions, during pyrazinamide therapy in children.
  • Further investigation may be warranted to elucidate the precise mechanism of pyrazinamide-induced neurotoxicity in pediatric patients.
  • This case underscores the importance of individualized treatment monitoring and risk-benefit assessment in pediatric tuberculosis management.

Related Experiment Videos